Elsevier Inc.

SHERPA: Unknown

People

  1. Rudin
    Rudin
  2. De Stanchina
    De Stanchina
  3. Arcila
    Arcila
  4. Baine
    Baine
  5. Beras
    Beras
  6. Buonocore
    Buonocore
  7. Chang
    Chang
  8. Drilon
    Drilon
  9. Jungbluth
    Jungbluth
  10. Kris
    Kris

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (16)
  2. Department of Medicine (16)
  3. GSK Faculty (16)
  4. Solid Tumor Oncology Division (16)
  5. Thoracic Oncology (16)
  6. Sloan Kettering Institute Postdocs (7)
  7. Radiology, Department of (4)
  8. Radiochemistry and Imaging Sciences Service (3)
  9. Sloan Kettering Institute Faculty (2)
  10. Body Imaging Service (1)
Search Within
  1. "Charles Rudin"
  2. "John Poirier"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (6)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (16)
  2. Department of Medicine (16)
  3. GSK Faculty (16)
  4. Solid Tumor Oncology Division (16)
  5. Thoracic Oncology (16)
  6. Sloan Kettering Institute Postdocs (7)

More Groups

People
  1. Charles Rudin (16)
  2. John Poirier (16)
  3. Elisa De Stanchina (7)
  4. Benjamin Lok (4)
  5. James Laird (4)
  6. Brandon Carney (3)

More People

Years
  1. 2020 (1)
  2. 2019 (3)
  3. 2018 (3)
  4. 2017 (2)
  5. 2016 (2)
  6. 2015 (3)

More Years

Publications
  1. Journal of Thoracic Oncology (12)
  2. International Journal of Radiation Oncology, Biology, Physics (4)

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: A comprehensive immunohistochemical and histopathologic characterization
    Journal Article

    Baine, M. K.; Hsieh, M. S.; Lai, W. V.; Egger, J. V.; Jungbluth, A. A.; Daneshbod, Y.; Beras, A.; Spencer, R.; Lopardo, J.; Bodd, F.; more...
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • PET imaging of [(18)F]PARP inhibitor as a pharmacodynamic biomarker of talazoparib in small cell lung cancer PDXs
    Meeting Abstract

    Lok, B.; Laird, J.; Carney, B.; Kossatz, S.; De Stanchina, E.; Reiner, T.; Poirier, J.; Rudin, C.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Positron-emission tomographic imaging of a fluorine 18-radiolabeled Poly(ADP-ribose) polymerase 1 inhibitor monitors the therapeutic efficacy of talazoparib in SCLC patient-derived xenografts
    Journal Article

    Laird, J.; Lok, B. H.; Carney, B.; Kossatz, S.; de Stanchina, E.; Reiner, T.; Poirier, J. T.; Rudin, C. M.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Acquired BRAF rearrangements induce secondary resistance to EGFR therapy in EGFR-mutated lung cancers
    Journal Article

    Vojnic, M.; Kubota, D.; Kurzatkowski, C.; Offin, M.; Suzawa, K.; Benayed, R.; Schoenfeld, A. J.; Plodkowski, A. J.; Poirier, J. T.; Rudin, C. M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • SLFN11 expression and efficacy of PARP inhibitor therapy in extensive stage small cell lung cancer: ECOG-ACRIN 2511 study
    Meeting Abstract

    Owonikoko, T.; Dahlberg, S.; Sica, G.; Poirier, J.; Byers, L.; Rudin, C.; Wistuba, I.; Ramalingam, S.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • PARP inhibitor radiosensitization of small cell lung cancer differs by PARP trapping potency
    Meeting Abstract

    Lok, B.; Laird, J.; Ma, J.; De Stanchina, E.; Poirier, J.; Rudin, C.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • PARP trapping by talazoparib is a potent mechanism of radiosensitization in small cell lung cancer cell lines and patient-derived xenografts
    Meeting Abstract

    Laird, J. H. Jr; Lok, B. H.; Ma, J.; Bell, A.; De Stanchina, E.; Poirier, J.; Rudin, C. M.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • [(18)F]PARPi PET as a marker of intratumoral talazoparib level in small cell lung cancer
    Meeting Abstract

    Laird, J. H.; Lok, B. H.; Carney, B.; Kossatz, S.; Ma, J.; Bell, A.; Shah, N.; Sadique, A.; De Stanchina, E.; Reiner, T.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Histone code aberrancies in small cell lung cancer
    Journal Article

    Gardner, E. E.; Poirier, J. T.; Rudin, C. M.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • SLFN11 is necessary for single agent sensitivity to talazoparib, a potent PARP inhibitor, but not for radiosensitization in small cell lung cancer (SCLC) cell lines and patient-derived xenografts (PDX)
    Meeting Abstract

    Lok, B. H.; Feng, Y.; Gardner, E. E.; Yu, G. K.; Ru, Y. K.; Riaz, N.; deStanchina, E.; Powell, S. N.; Shen, Y. J.; Poirier, J. T.; more...
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save